EGFR and neoplasm: In vivo studies confirm dioscin’sefficacy in suppressing tumor development, highlighting its potentialas a promising treatment strategy through targeting the EGFR-survivingaxis,35 resulting in a particular focuson EGFR as a target for the search for new anticancer steroidal saponins.